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Traumatic injuries of articular cartilage result in the formation of a cartilage lesion and con-
tribute to cartilage degeneration and the risk of osteoarthritis (OA). A better understanding
of the framework for the formation of a cartilage lesion formation would be helpful in therapy
development. Toward this end, we present an age and space-structured model of articular
cartilage lesion formation after a single blunt impact. This model modifies the reaction-
diffusion-delay models in Graham et al. (2012) (single impact) and Wang et al. (2014) (cyclic
loading), focusing on the “balancing act” between pro- and anti-inflammatory cytokines.
Age structure is introduced to replace the delay terms for cell transitions used in these
earlier models; we find age structured models to be more flexible in representing the
underlying biological system and more tractable computationally. Numerical results show
a successful capture of chondrocyte behavior and chemical activities associated with the
cartilage lesion after the initial injury; experimental validation of our computational results
is presented. We anticipate that our in silico model of cartilage damage from a single blunt
impact can be used to provide information that may not be easily obtained through in in vivo
or in vitro studies.
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1. INTRODUCTION
The degenerative joint disease known as osteoarthritis (OA) is
among the most common causes of disability worldwide. While
OA involves multiple joint tissues including bone, tendons, liga-
ments and synovium, articular cartilage degeneration, and erosion
is the proximal cause of loss of joint function. Articular cartilage is
a thin layer of connective tissue that covers the ends of long bones
in synovial joints such as the shoulder,hip,knee,and ankle,where it
distribute mechanical loads and allows for smooth joint motion.
These functions are attributable to the unique composition and
structure of cartilage extracellular matrix (ECM),which consists of
water (>70%), proteoglycan (15%), and collagen (15%) (Martin
et al., 2011). Aggrecan, the major cartilage proteoglycan, is heav-
ily decorated with negatively charged sulfate groups, which retain
water in the tissue. Large complexes of aggrecan are trapped within
the matrix by a collagen fibril network. The resistance of cartilage
to compression and its ability to distribute loads is largely due to
this macromolecular arrangement, and aggrecan depletion or col-
lagen degradation radically reduces mechanical strength (Farndale
et al., 1982; Lu et al., 2011).
Even though articular cartilage is only 1–3 mm thick, it has four
distinct zones (superficial, transitional, radial, calcified). Different
zones have different cell morphologies, matrix composition, and
collagen fibril properties. Compared to other zones, the superficial
zone is specialized to resist tensile stresses and minimize surface
friction. In this paper, we focus on the properties of the superficial
zone. We assume the solid cartilage matrix to be a homoge-
neous system, so that the chemical and cell properties remain the
same inside the space. Cartilage cells, known as chondrocytes, are
distributed sparsely within the tissue (104 cells/mm3). They are
largely trapped inside the ECM, so there is no appreciable cell
motility. Chondrocytes are solely responsible for the maintenance
of the cartilage matrix, and engage in complex biochemical sig-
naling/regulation via the synthesis and release or recognition of
signaling molecules such as cytokines and oxidants, among oth-
ers. We classify chondrocytes to be in different states in our model
with respect to the chemical signaling processes. In addition to
synthesizing ECM components, chondrocytes also release matrix
proteases that cause matrix degradation.
There are various ways to cause traumatic articular cartilage
injury, but they all share high loading rates and a high peak stress
amplitude, which initiates the damage (lesion). The damage done
by injuries seldom heals spontaneously and often leads to the
progressive cartilage degeneration characteristic of post-traumatic
osteoarthritis (PTOA). The strain in the superficial zone under a
single blunt impact can easily exceed 40%, and when combined
with the high loading rate and excessive stress, is lethal to chon-
drocytes and detrimental to the ECM. Chondrocyte death inside
the superficial zone can be assumed to be directly caused by this
impact. The main focus of most therapies for PTOA has been to
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FIGURE 1 | Schematic of the articular cartilage lesion formation
process due to a single blunt impact.
prevent chondrocyte death and dysregulation. The chondrocyte
depletion and ECM degradation process is illustrated in Figure 1.
Cartilage damage initiates the production of alarmins, such as
damage associated molecular patterns (DAMPs) (Bianchi, 2007),
which can induce the release of pro-inflammatory cytokines such
as interleukin-6 (IL-6), TNF-α, IL-1 α, and IL-1 β. A previous
microarray study suggests that TNF-α might be the early media-
tor; however, IL-1 β is the cytokine that sustains the degradation
(Martin et al., 2011). In this model, we use IL-6 to represent the
entire cytokine family for model simplicity. Other cytokines such
as TNF-α or IL-1 β can be easily added to the equations, but
doing so would provide limited benefit with the need for additional
parameter estimation and model complexity.
Pro-inflammatory cytokines are the main reason for cell apop-
tosis. Moreover, the pro-inflammatory cytokines can cause severe
aggrecan depletion, which leads to loss of strength and elevated
strain in affected cartilage. Even though it is quite limited, chon-
drocytes still have some self-repair ability. Anti-inflammatory
cytokines such as erythropoietin (EPO) can antagonize the effect
of pro-inflammatory cytokines and result in reduced cell apoptosis
and ECM degradation. The “balancing act” (Graham et al., 2012)
between pro-inflammatory and anti-inflammatory cytokines is
the essential mechanism determining whether a cartilage lesion
will heal or expand in size.
This paper is organized as follows. We describe the mathe-
matical models and numerical methods used to solve the model
equations. We then describe the materials and methods used for
the experimental validation of our computational results. We then
present the computational results and the experimental validation.
We finish with a discussion of these results.
2. MATERIALS AND METHODS
2.1. MATHEMATICAL MODEL AND NUMERICAL METHODS
In this section, we describe the age- and space-structured model
developed for the inflammatory response after a single blunt
impact injury. The cartilage lesion caused by a single severe
traumatic event was described in a reaction-diffusion-delay model
by Graham et al. (2012) and Graham (2013). In our model, we use
age structure instead of delay terms to model the delayed transi-
tions between cell states. This change in modeling approach was
necessitated by the increased complexity of the interactions we are
representing mathematically. Age structure is more efficient com-
putationally than the use of delay terms, and is more flexible in
representing transitions between cell states.
2.1.1. Components of the system
We assume circular symmetry so that the system can be reduced
to a one-dimensional model with respect to space. The compo-
nents of the system depend on radius (r), age (a), and time (t ).
The time scales for our cell transitions are denoted by τ 1 and τ 2.
We also assume that the initial blunt impact occurred on a small
region near the origin with radius smaller than 0.25 cm, in a spatial
domain with a total radius of 2.5 cm.
There are two main categories of components in our mathe-
matical model, cells and chemicals. A schematic of the system is
presented in Figure 1.
Let r denote radius, a time since signaled (i.e., age in current
state), and t time (i.e., wall clock). The cell components are
• CU (r, t )= population density (cells per unit area) of healthy
cells not yet signaled by ROS.
• CT (r, a, t )= population density of healthy cells signaled by ROS
and in the process of becoming catabolic.
• CE (r, t )= population density of healthy cells signaled by ROS
and starting to produce EPO (roughly 20–24 h after being
signaled).
• ST (r, a, t )= population density of sick cells in the cata-
bolic state. Healthy cells signaled by alarmins (DAMPs) and
inflammatory cytokines (IL-6, TNF-α) enter into the catabolic
state. Catabolic cells start to synthesize inflammatory cytokines
and ROS.
• SA (r, t )= population density of EPOR-active cells. Catabolic
cells signaled by inflammatory cytokines enter the EPOR-active
state. EPOR-active cells express a receptor (EPOR) for EPO;
however, there is a 8–12 h time gap before a cell expresses
the EPO receptor after it was signaled to become EPOR-active
(Brines and Cerami, 2008). After EPOR-active cells express a
receptor for EPO, they may switch back to the healthy state CU
when signaled by EPO.
• DA (r, t )= population density of apoptotic cells. Catabolic cells
signaled by alarmins and inflammatory cytokines enter the
apoptotic state. EPOR-active cells will also become apoptotic
after signaled by inflammatory cytokines. Apoptotic cells do
not play an explicit role in the mathematical model.
• DN (r, t )= population density of necrotic cells. In our model,
necrotic cells are only created by the initial blunt impact and
release alarmins (DAMPs) into the system. Before cells become
necrotic, cells release a small amount of ROS. Fully necrotic cells
cannot produce ROS and are eventually cleared from the system.
We assume negligible motility on the part of chondrocytes, so
there are no diffusion terms for the cells equations. The different
cell states correspond to the different chemical signals. The injury
kills cells inside the impact area by rendering them necrotic (DN).
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The other cells adjacent to the impact area transit from “healthy”
(CU, CT, CE) to “sick” (ST, SA) and then “dead” (apoptotic DA)
states. Since apoptotic cells (DA) do not play an explicit role in
the system, they are not expressed explicitly in our mathematical
model, but are instead represented by the sink terms inside the ST
and SA equations.
The chemical components are
• R (r, t )= concentration of reactive oxygen species (ROS). ROS
triggers healthy cells to change states.
• M (r, t )= concentration of alarmins (DAMPs) released by
necrotic cells and ECM degradation. DAMPs signal healthy cells
CT to enter the catabolic state ST, and together with inflamma-
tory cytokines such as IL-6, cause catabolic cells ST to become
apoptotic.
• F (r, t )= concentration of inflammatory cytokines (IL-6) pro-
duced by catabolic cells (ST). These inflammatory cytokines
– signals healthy cells (CT) to enter the catabolic state (ST),
– signal catabolic cells (ST) to enter the EPOR-active state
(Brines and Cerami, 2008),
– cause both catabolic and EPOR-active cells to become
apoptotic,
– degrade the extracellular matrix, which in turn increases
the level of DAMPs, resulting in further damage of the
system. The degradation of ECM is a slow and complex
process. However, we assume for mathematical convenience
that inflammatory cytokines directly damage ECM,
– limit the production of EPO.
• P (r, t )= concentration of erythropoietin (EPO). EPO is pro-
duced exclusively by CE in our model. Inflammatory cytokines
suppress this process. EPO helps EPOR-active cells (SA) switch
back to the healthy state CU. The effects of EPO depend on
its concentration. When the concentration of EPO passes the
threshold Pc (Brines and Cerami, 2008), the spread of inflam-
mation can be slowed by terminating the effect of inflammatory
cytokines and alarmins on the system. We also assume that CE
cells revert to CU when the EPO level exceeds the Pc threshold.
We assume that the chemicals diffuse throughout the whole
region. The diffusion coefficients were estimated by Graham et al.
(2012) and Leddy and Guilak (2003). Chemicals decay after a cer-
tain time, and the decay rate can be approximated by their half lives
(Eckardt et al., 1989; Wedlock et al., 1996; Ito et al., 2008). However,
the decay of ROS is almost instantaneous under the superoxide
dismute SOD, so the decay rate needs to be adjusted to fit the
mathematical model. The inflammatory cytokines such as IL-6
and TNF-α are the main cause of cartilage lesion formation. EPO
plays an opposing role by helping cell recovery and limiting the
inflammation (Brines and Cerami, 2008). Our model captures the
balance between these pro-inflammatory and anti-inflammatory
cytokines.
In addition to the chemicals, we track the extracellular matrix
density:
• U (r, t )= density of extracellular matrix (ECM). ECM is
degraded by inflammatory cytokines and releases alarmins.
The degradation of ECM is measured by the decrease in the
concentration of SO4 (Farndale et al., 1982).
2.1.2. Model equations
The equations for the chemical components of our system are
∂t R(r , t )︸ ︷︷ ︸
ROS
= 1
r
∂r (rDRRr )︸ ︷︷ ︸
diffusion
− δRR︸︷︷︸
natural decay
+ σRST︸ ︷︷ ︸
production by ST
, (1a)
∂t M (r , t )︸ ︷︷ ︸
DAMPs
= 1
r
∂r (rDM Mr )︸ ︷︷ ︸
diffusion
− δM M︸ ︷︷ ︸
natural decay
+ σM DN︸ ︷︷ ︸
production by DN
+ δU U F
λF + F︸ ︷︷ ︸
production by ECM
, (1b)
∂t F(r , t )︸ ︷︷ ︸
IL−6
= 1
r
∂r (rDF Fr )︸ ︷︷ ︸
diffusion
− δF F︸︷︷︸
natural decay
+ σF ST︸ ︷︷ ︸
production by ST
, (1c)
∂t P(r , t )︸ ︷︷ ︸
EPO
= 1
r
∂r (rDP Pr )︸ ︷︷ ︸
diffusion
− δP P︸︷︷︸
natural decay
+ σP CE R
λR + R
3
3+ F︸ ︷︷ ︸
production by CE , controlled by F
. (1d)
The initial and boundary conditions are
∂r R(0, t ) = ∂r M (0, t ) = ∂r F(0, t ) = ∂r P(0, t ) = 0,
R (r , 0) = σR · DN (r , 0) , and M (r , 0) = F (r , 0) = P (r , 0) = 0.
Our chemical equations are similar to those in Graham et al.
(2012). A very significant change is that the system is triggered by
ROS released by cells as they become necrotic. The initial condi-
tion of ROS is not zero. We use the diffusion and natural decay
rates of chemicals as estimated in Wang et al. (2014).
The ECM is assumed to be degraded by inflammatory cytokines
such as IL-6, measured in terms of decreased proteoglycan concen-
tration in the matrix. When ECM is intact, the sulfate groups are
kept inside the ECM. The release of sulfate groups is an indication
of ECM degradation, which can be estimated by the decrease in
concentration of SO4. The average concentration of SO4 in nor-
mal undamaged cartilage is 30 g/L (Farndale et al., 1982), which is
the initial density of ECM in this model. EPO concentration also
affects ECM degradation.
We define the Heaviside function,
H (θ) =
{
1, θ > 0,
0, θ < 1.
(2)
The equation for the ECM dynamics is
∂t U (r , t )︸ ︷︷ ︸
ECM
= −δU U F
λF + F H (Pc − P)︸ ︷︷ ︸
degradated by alarmins, checked by EPO
, (3)
with initial condition U (r, 0)= 30 mg. The Heaviside function
H (Pc− P) represents the property that ECM degradation can be
terminated when the level of P exceed Pc.
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A substantial difference between our model and Graham et al.
(2012) is that we use age structure to represent the time delays
for cells to become EPO producing and EPOR-active, instead of
delay terms. This gives us a system that is more tractable computa-
tionally and more flexible in representing the transitions. Another
major difference is that we capture more fully the dynamics among
healthy cells. We separate healthy cells into three states, CU, CT, and
CE. Since there are only two transitions, CT→CE and ST→ SA,
that involve a time delay, we include age structure a in only the
equations for CT and ST. Following Ayati (2007a), we capture the
sharp age of transition using the function
γ (a − amax) = γ0
σ
(
tanh
(
a − amax
σ
)
+ 1
)
, (4)
where σ is the spread parameter and γ 0 is the height parameter.
For a fixed γ 0 and σ→ 0, cells CT and ST switch their states to
CE and SA all at the same age amax. When σ is small but not zero,
this behavior is smoothed out, better representing the underlying
biology. For definiteness, we choose amax= 1 for CT→CE and
amax = 12 for ST→ SA.
The equation for the population density of healthy cells not yet
signaled by ROS is
∂t CU (r , t ) = α1SA P
λP + P︸ ︷︷ ︸
SA
EPO−−→CU
+α2H (P − Pc )CE︸ ︷︷ ︸
CE
EPO−−→CU
−β13CU R
λR + R︸ ︷︷ ︸
CU
ROS−−→CT
,
(5a)
with initial condition
CU (r , 0) =
{
0, 0 ≤ r ≤ 0.25cm
100000 cells/cm2, otherwise
. (5b)
The equation for the population density of healthy cells signaled
by ROS and in the process of becoming catabolic is
∂t CT (r , a, t )+ ∂aCT (r , a, t ) =
− β11 M
λM +M H (Pc − P)CT (r , a, t )︸ ︷︷ ︸
CT
DAMPs−−−−→ST
− β12 F
λF + F H (Pc − P)CT (r , a, t )︸ ︷︷ ︸
CT
TNF−α−−−−→ST
− κ2γ (a − τ2) R
λR + R CT (r , a, t )︸ ︷︷ ︸
CT
ROS−−→CE
, (6a)
with age boundary condition
CT (r , 0, t ) = β13CU R
λR + R︸ ︷︷ ︸
CU
ROS−−→CT
, (6b)
and initial condition CT (r, a, 0)= 0.
The equation for the population density of healthy cells signaled
by ROS and producing EPO is
∂t CE (r , t ) =
∫ ∞
0
κ2γ (a − τ2) R(r , t )
λR + R(r , t )CT (r , a, t )da︸ ︷︷ ︸
CT
τ2 delay−−−−→CE
− α2H (P − Pc )CE︸ ︷︷ ︸
CE
EPO−−→CU
, (7)
with initial condition CE (r, 0)= 0.
The equations for the population density of sick cells in the
catabolic state is
∂t ST (r , a, t )+ ∂aST (r , a, t ) = −µST F
λF + F
M
λM +M ST (r , a, t )︸ ︷︷ ︸
ST
TNF−α, DAMPs−−−−−−−−−→DA
− η · γ (a − τ1) F
λF + F ST (r , a, t )︸ ︷︷ ︸
ST
TNF−α−−−−→SA
,
(8a)
with age boundary condition
ST (r , 0, t ) =
∫ ∞
0
(β11CU
M
λM +M H (Pc − P)︸ ︷︷ ︸
CT
DAMPs−−−−→ST
+ β12CU F
λF + F H (Pc − P)︸ ︷︷ ︸
CT
TNF−α−−−−→ST
)CT (r , a, t )da, (8b)
and initial condition ST (r, a, 0)= 0.
The equation for the population density of EPOR-active sick
cells is
∂t SA(r , t ) =
∫ ∞
0
η · γ (a − τ1) F(r , t )
λF + F(r , t )ST (r , a, t )da︸ ︷︷ ︸
ST
TNF−α−−−−→SA
− α1SA P
λP + P︸ ︷︷ ︸
SA
EPO−−→CU
−µSA
F
λF + F SA︸ ︷︷ ︸
SA
TNF−α−−−−→DA
, (9)
with initial condition SA (r, 0)= 0.
The equation for the necrotic cell population is
∂t DN (r , t ) = − µDN DN︸ ︷︷ ︸
natural decay
, (10a)
with initial condition
DN (r , 0) =
{
100000 cells/cm2, 0 ≤ r ≤ 0.25cm,
0, otherwise.
(10b)
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2.1.3. Numerical methods
The computational methods used to solve the age- and space-
structured differential equations were developed and analyzed in
Ayati (2000, 2007a) and Ayati and Dupont (2002, 2009) and have
been used effectively and efficiently in the modeling and simu-
lation of biofilms (Ayati and Klapper, 2007, 2012; Klapper et al.,
2007; Ayati, 2011), avascular tumor invasion (Ayati et al., 2006),
and Proteus mirabilis swarm colony development (Ayati, 2006,
2007b, 2009). Numerical efficiency is the main reason that we
use age structure rather than delay terms in the model in this
paper. To solve the model equations in Graham et al. (2012) and
Wang et al. (2014), the authors first did a semi-discretization in
space and then solved the resulting system of ordinary delay dif-
ferential equations using the Matlab function dde23 (Shampine
and Thompson, 2001). The function dde23 uses an explicit time
integration method. As a result, the stability constraints of the
semi-discretized system result in very small time steps. Although
another numerical method for delay differential equations could
be constructed without such constraints, the need to store the past
history of a large spatial system renders the delay approach much
less efficient than using age structure; the extra dimension of age is
accurately discretized with far less data storage and computation
(we use 129 age intervals in the simulations in this paper). The
time discretization is adaptive (Ayati and Dupont, 2005) and con-
trolled by a tolerance parameters. We use center finite differences
to discretize the diffusion terms.
The relative errors obtained in our computational convergence
studies of the numerical results are given in Table 1. For simplic-
ity, we vary the number of spatial intervals. We see that even for
a fairly coarse discretization using 100 intervals, we have relative
errors of <0.3%.
2.2. EXPERIMENTAL MATERIAL AND METHODS
2.2.1. Generation of cartilage specimens
Osteochondral explants were surgically excised from bovine lateral
tibial plateaus (25 mm× 25 mm× 10 mm). All specimens were
allowed to equilibrate for two days in culture media in a low
oxygen environment (5% O2, 5% CO2). After equilibration (day
0), explants either underwent a sham impact procedure or were
impacted with a 5.5 mm rounded edge indenter from a drop tower,
imparting an energy of 2.18 J/cm2. Unimpacted explants were
removed on day 0, preserved and embedded in paraffin. Impacted
explants were placed back in fresh culture media, and removed at
day 1, 7, or 14 for preservation and paraffin embedding. Culture
media was changed every two days for explants cultured out to day
7 or 14.
2.2.2. Immunohistochemistry
Paraffin embedded cartilage explants were cut into 5µm thick
sections on glass slides to be processed for immunohistochemical
detection of interleukin-6 (IL-6), erythropoietin (EPO),or the ery-
thropoietin receptor (EPOR). All cartilage sections for each stain
were processed in batch at the same time under identical condi-
tions. The sections were deparaffinized, quenched of endogenous
peroxidase activity, and then underwent antigen retrieval using
a 0.01 M citric acid solution for 4 h at 65°C. Non-specific anti-
gen binding was then blocked for 1 h with PBS containing 10%
Table 1 |Table of relative errors.
Variable number of
age intervals
100 200 400 800
Healthy normal (CU) 4.1060E-04 2.2420E-05 2.8220E-06 9.5317E-07
Healthy pre-catabolic
(CT)
1.0342E-03 1.1883E-04 8.5328E-05 1.0001E-04
Healthy EPO
producing (CE)
1.4318E-03 7.7614E-05 1.0574E-05 3.1481E-06
Catabolic (ST) 1.6966E-03 1.8716E-04 4.1704E-05 6.8092E-05
EPOR-active (SA) 1.7993E-03 1.0926E-04 1.2838E-05 4.6493E-06
ECM (M ) 5.5031E-07 6.9499E-08 2.8295E-08 1.5726E-08
IL-6 (F ) 8.5298E-04 7.1301E-05 1.5445E-05 5.9705E-06
EPO (P ) 1.8318E-03 1.1066E-04 1.9243E-05 4.6840E-06
DAMPs (M ) 1.8736E-03 8.5046E-05 2.8458E-05 6.3479E-06
ROS (R) 2.1849E-03 5.2076E-04 1.2122E-04 3.0536E-05
For each dependent variable in the model, we show the relative 2-norm error
over all spatial and temporal nodes. Relative errors are calculated by comparing
the solution using n spatial intervals with the solution using 2n spatial intervals.
Even for a fairly coarse discretization using 100 intervals, we have relative errors
of < 0.3%.
goat serum, 1% bovine serum albumin (w/v), and 0.1% tween 20.
This blocking solution was then used to dilute the primary anti-
bodies against IL-6 (Abcam ab193799), EPO (Abcam ab65394),
and the EPOR (Abcam ab83696) at a ratio of 1:100 from their
starting concentration. The solution containing the primary anti-
body was incubated on the slides overnight at 4°C. The slides were
then rinsed and blocking solution applied for 30 min at room
temperature. A biotinylated secondary antibody against the pri-
mary antibody was then incubated on the slides at a 1:250 dilution
(Vector Labs). The slides were then rinsed and incubated with the
VECTASTAIN® ABC Reagent (Vector Labs) for 30 min at room
temperature. After another rinsing, DAB (3, 3-diaminobenzidine)
HRP substrate solution (Vector Labs DAB substrate kit) was incu-
bated on the sections for 2–10 min (depending on primary anti-
body). The sections were then rinsed for a final time, counter
stained with eosin, dehydrated, and a glass coverslip was attached
and sealed with permount (Fisher).
Slides were then digitally scanned on an Olympus VS110. The
Olympus software controlled the slide stage in all axes and auto-
matically focused/captured high resolution images (322 nm/pixel)
which were then tiled together, resulting in full explant immuno-
histochemically labeled images. The resolution of the resulting
images was then reduced to 20% of their original size and exported
as tiff images for analysis.
To obtain the validation data, we analyzed 12 cartilage slices.
The slices were separated into six categories with two slices per cat-
egory: EPO at days 1, 7, 14; and IL-6 at days 1, 7, 14. The length of
each slice is around 1′′ (2.5 cm approximately). The sham impact
was placed in the middle of each cartilage slice and formed a dent
(see Figure 2). Cells inside the cartilage slices were stained by the
antibodies, and the number of cells per area corresponds to the
relative concentrations of EPO and IL-6.
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FIGURE 2 | Slices of articular cartilage created at 1, 7, and
14days after a single blunt impact. The impact site appears as a
dent at the top of each image. The squares in each region are the
zoomed areas shown in Figure 3. These slices have been stained to
measure EPO concentrations, which are shown to increase as time
progresses.
FIGURE 3 | Zoomed areas from Figure 2. These samples have been stained to measure EPO concentrations, which are shown to increase as time progresses.
For image processing, we split each slice into two half-slices,
divided at the point of impact. From these we could obtain four
measurements of each of EPO and IL-6 at each radial value. We fur-
ther subdivided each half-slice into pieces approximately 0.15 cm
long; the pieces correspond roughly to the radius intervals [0, 0.15]
cm, [0.15, 0.3] cm, [0.3, 0.45] cm, [0.45, 0.6] cm, [0.6, 0.75] cm,
and [0.75, 0.9] cm.
We cropped an 800× 800 pixel sample image from each
piece and estimated the cell numbers in each sample. Figure 3
shows example samples from slices shown in Figure 2. The
800× 800 pixel sample image has an area of 0.0166 cm2. We have
four such sample images per radius interval. Average cell count
is used as the estimator of cell numbers in each radius interval.
The EM algorithm and K-mean methods were applied for the cell
segmentation. The upper threshold of the positive cell size is 50–
150µm2 (approximately 20–60 pixels), while the lower threshold
of the positive cell size is 25–30µm2 (approximately 10–15 pixels).
3. RESULTS
3.1. COMPUTATIONAL RESULTS
We simulate the change of the chondrocyte population densities
over a 14-day period after an initial cartilage injury in the center
of a disk with a radius of 2.5 cm. The radius of the area of impact
is 0.25 cm. We assume the initial cells density is 100,000 cells/cm2.
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Table 2 |Table of parameters.
Parameter Value Units Source
DR 0.1 cm
2
day Graham et al. (2012)
DM 0.05 cm
2
day Graham et al. (2012)
DP 0.005 cm
2
day Graham et al. (2012)
DF 0.05 cm
2
day Graham et al. (2012)
δR 60 1day Wang et al. (2014)
δM 0.5545 1day Ito et al. (2008), Wang
et al. (2014)
δF 0.5545 1day Wedlock et al. (1996),
Wang et al. (2014)
δP 3.326 1day Brines and Cerami (2008),
Wang et al. (2014)
δU 0.0193 1day Lu et al. (2011), Wang et al.
(2014)
σR 0.0024 nanomolar·cm
2
day·cells Zhou et al. (2004), Wang
et al. (2014)
σM 5.17×10−7 nanomolar·cm2day·cells Terada et al. (2011), Wang
et al. (2014)
σ F 2.35×10−7 nanomolar·cm2day·cells Terada et al. (2011), Wang
et al. (2014)
σP 4.2×10−5 nanomolar·cm2day·cells Brines and Cerami (2008),
Wang et al. (2014)
σU 0.0154 nanomolar·cm
2
day·cells Lu et al. (2011), Wang et al.
(2014)
3 0.5 nanomolar Approximated
λR 5 nanomolar Approximated
λM 0.5 nanomolar Approximated
λF 0.5 nanomolar Approximated
λP 0.5 nanomolar Approximated
α1 1 1day Approximated
α2 1 1day Approximated
β11 100 1day Approximated
β12 50 1day Approximated
β13 10 1day Approximated
κ1 10 1day Approximated
κ2 10 1day Approximated
Pc 1 1day Brines and Cerami (2008),
Wang et al. (2014)
µST 0.5
1
day Approximated
µSA 0.1
1
day Approximated
µDN 0.05
1
day Approximated
τ1 0.5 days Graham et al. (2012)
τ2 1 days Graham et al. (2012)
The parameters used for the simulations are shown in Table 2.
Most of the parameters are the same as in Wang et al. (2014), which
contains detailed descriptions of how many of the parameters were
determined from the literature. The parameters α1, β11, β12, β13,
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FIGURE 4 |The densities of healthy cells (CU, CT, CE) at t =0, 1, 5, 7, 10,
14days. We show the integral of CT over all ages to obtain a total
population density. CU is graphed with a solid line, CT with a dash-dot line,
and CE with a dashed line.
κ1, and κ2, which determine the cells transition rates, have been
changed or added to account for the transition from delay terms
to age structure in our model. Because our trigger P > Pc is never
reached, the value of α2 is irrelevant. We include it for complete-
ness of the general model. Similarly,3 is set sufficiently high that
the effect of inflammatory cytokines on the transition to EPO-
producing healthy cells (CE) is neglected; this transition is assumed
to be dominated by ROS (R) in these simulations.
When we initiate the simulation at t = 0, a population of
necrotic cells occupies the impact area. We show our results as
six series of snapshots in time, taken at t = 0, 1, 5, 7, 10, 14 days.
We plot days 1, 7, and 14 in particular since those correspond to
the attendant experiments. The time length of 14 days is used in
our simulation as it is typical of such experimental set-ups.
Figure 4 shows the population densities of the three states of
healthy cells. Figure 5 shows the healthy, catabolic, and EPOR-
active cell population densities. Figure 6 shows the live cell pop-
ulation densities, i.e., the populations of all healthy and sick cell
classes. Figure 7 compares the concentrations of IL-6 (our rep-
resentative inflammatory cytokine) and EPO (our primary anti-
inflammatory cytokine). Our focus is on the balance of pro- and
anti-inflammatory cytokines. We choose IL-6 as representative
since it a known inflammatory cytokine. We remark that TNF-α is
also a viable choice. Figure 8 shows the concentration of DAMPs.
Figure 9 shows the concentration of ROS.
Simulation results show that after the initial injury, the cells
adjacent to the impact area quickly sense the release of ROS
and begin to switch states. At the same time, DAMPs released by
necrotic cells start to trigger the pre-catabolic cell population (CT)
to become catabolic (ST). These catabolic cells then start to pro-
duce more DAMPs, inflammatory cytokines, and ROS that aggra-
vate the inflammation. Because of the non-zero transition times
in the CT→CE and ST→ SA transitions, cells cannot produce
the anti-inflammatory cytokine EPO nor express a receptor for
www.frontiersin.org March 2015 | Volume 3 | Article 25 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wang et al. Model of cartilage
0 1 2
0
5
10 x 10
4
ce
lls
/c
m
2
t=0
0 1 2
0
5
10 x 10
4 t=1
0 1 2
0
5
10 x 10
4 t=5
0 1 2
0
5
10 x 10
4
cm
ce
lls
/c
m
2
t=7
0 1 2
0
5
10 x 10
4
cm
t=10
0 1 2
0
5
10 x 10
4
cm
t=14
FIGURE 5 |The densities of healthy, catabolic and EPOR-active cells
(CU +CT +CE, ST, SA) at t =0, 1, 5, 7, 10, 14days. The contribution of
pre-catabolic cells is the integral of CT over all ages to obtain a total
population density. We show the integral of ST over all ages as well to
obtain a total population density. Healthy cells are graphed with a solid line,
catabolic cells ST with a dash-dot line, and EPOR-active cells SA with a
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FIGURE 6 |The density of live cells, (CU +CT +CE +ST +SA) at t =0, 1, 5,
7, 10, 14days. We show the integrals of CT and ST over all ages to obtain
total population densities.
EPO immediately. The earliest an anti-inflammatory response can
occur is day 1 (shown in the simulation figures). In Figures 4–6,
we see that the population density of healthy cells CU starts to
decline as those cells switch to the pre-catabolic and catabolic
states (CT and ST). By day 5, we observe a significant density of
pre-catabolic (CT), EPO producing (CE) and catabolic (ST) cells.
From day 5 onward, there is some cell death adjacent to the impact
area followed by the continuing spread of the cartilage lesion. Due
to the low release rate of EPO by the CE population, we do neither
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FIGURE 7 |The concentrations of IL-6 (F ) and EPO (P ) at t =0, 1, 5, 7, 10,
14days. IL-6 is graphed using a solid line and EPO is graphed using a
dashed line.
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FIGURE 8 |The concentration of DAMPs (M) at t =0, 1, 5, 7, 10, 14days.
have significant conversion of CE cells to CU cells nor do EPOR-
active cells (SA) recover to a healthy state. By day 10, there is an
appreciable density of EPO-producing cells (CE), and EPOR-active
cells (SA) awaiting EPO to finish their conversion to the healthy
state (CU). However, the proportion of sick cells to healthy cells
continues to grow during the simulation period, which was chosen
to match common experimental set-ups.
In the simulation period of 14 days, the decrease of ECM den-
sity is quite small. This is because ECM degradation is a much
slower process than the apoptosis of cells.
Figures 7–9 show the concentration of the chemical concen-
trations: IL-6, EPO, DAMPs, and ROS. The EPO concentration is
too low to trigger the anti-inflammatory process efficiently, which
is an expected result (Brines and Cerami, 2008). Since cells will
release a small amount of ROS before they become necrotic, the
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FIGURE 9 |The concentration of ROS (R ) at t =0, 1, 5, 7, 10, 14days.
concentration of ROS is not zero inside the impact area at t = 0.
Although the initial burst of ROS decreases rapidly due to the fast
decay rate of ROS, the production of ROS is continued by cata-
bolic cells ST. This results in a lower but broader concentration of
ROS, as expected (Brouillette et al., 2013). DAMPs concentrations
peak are early at the site of the impact.
The main competition between pro- and anti-inflammatory
cytokines results in a steady increase of IL-6 across the cartilage,
whereas EPO is more heavily concentrated just outside the penum-
bra of the inflamed region. The net result is a slowing, but not full
cessation, of the spread of the inflammation.
We remark that in the simulations presented, we never reach the
threshold P > Pc. This is consistent with (Brines and Cerami,2008)
that chondrocytes alone cannot produce enough EPO to stop the
cartilage inflammation, so that H (Pc− P)= 1 and H (P − Pc)= 0
for all r and t. Brines and Cerami (2008) described the possibility
of EPO therapy for cartilage injury, in which case P may exceed
Pc. We note that the model we have formulated is set up to be
modified for such therapies.
3.1.1. Parameter sensitivity analysis
We examined the approximated parameters in Table 2 for sensitiv-
ity, with the exception of α2 and3, which do not affect the system
in these simulations, but are included in the model for general-
ity. Holding all other parameters to their base value in Table 2,
we perturbed a given parameter. We found a region around each
parameter base value where the qualitative behavior of the system
did not change. The perturbed values for each parameter and an
interval in which the system did not change qualitatively or appre-
ciably quantitatively are shown in Table 3. Specifically, as each
parameter was increased within its perturbation range, we found
most noticeably that the following densities and concentrations
decrease:
• for λR, EPOR-active cells (SA) and DAMPs (M );
• for λM, sick cells (ST, SA), IL-6 (F), ROS (R), and DAMPs (M );
Table 3 |Table of perturbed parameter values.
Parameter Base value Perturbed values Interval
λR 5 {1, 3, 7, 9} [3, 7]
λM 0.5 {0.1, 0.3, 0.7, 0.9} [0.3, 0.7]
λF 0.5 {0.1, 0.3, 0.7, 0.9} [0.3, 0.7]
λP 0.5 {0.1, 0.3, 0.7, 0.9} [0.3, 0.9]
α1 1 {0.1, 0.5, 1.5, 2} [0.5, 2]
β11 100 {50, 75, 125, 150} [60, 70]
β12 50 {40, 45, 55, 60} [40, 60]
β13 10 {1, 5, 15, 20} [5, 15]
κ1 10 {1, 5, 15, 20} [5, 20]
κ2 10 {1, 5, 15, 20} [5, 20]
µST 0.5 {0.1, 0.3, 0.7, 0.9} [0.1, 0.9]
µSA 0.1 {0.01, 0.05, 0.15, 0.2} [0.01, 0.2]
µDN 0.05 {0.01, 0.03, 0.07, 0.09} [0.01, 0.09]
For each of the approximated parameter values in the model, we show the
perturbed values in which we conducted additional simulations, and present an
interval in which we found no meaningful qualitative or quantitative change from
the simulation conductedwith the corresponding base parameter given inTable 2.
• for λF, EPOR-active cells (SA) and DAMPs (M );
• for λP, normal healthy cells (CU), pre-catabolic healthy cells
(CT), catabolic cells (ST), IL-6 (F), EPO (P), and DAMPs (M );
• for α1, all variables, except for EPOR-active cells (SA) and ECM
(U );
• for β11, all healthy cells (CU, CT, CE), ECM (U ), and EPO (P);
• for β12, all healthy cells (CU, CT, CE) and EPO (P);
• for β13, normal healthy cells (CU) and ECM (U );
• for κ1, healthy pre-catabolic cells (CT), catabolic cells (ST),
EPOR-active cells (SA), IL-6 (F), ROS (R), and DAMPs (M );
• for κ2, healthy pre-catabolic cells (CT), EPOR-active cells (SA),
IL-6 (F), ROS (R), and DAMPs (M );
• for µST , none (we see no appreciable change for the interval
around the base parameter);
• for µSA , none (we see no appreciable change for the interval
around the base parameter);
• for µDN , normal healthy cells (CU), pre-catabolic healthy cells
(CT), and all chemicals (R, M, F, P);
The most sensitive parameters in the system are λR,λM, and λF.
In particular, when these parameters are relatively small compared
to their base value, solutions that are otherwise monotone become
non-monotone or somewhat oscillatory.
3.2. EXPERIMENTAL VALIDATION
The sequence and distributions of the cell states match what is
expected from past and current understanding of the “penumbra”
around a lesion, in which an initial burst of pro-inflammatory
cytokine expression is eventually attenuated by an increase in
anti-inflammatory cytokine expression. Our major simulation
result predicting this progression (Figure 7) was mainly in agree-
ment with experimental results showing an acute post-injury
increase in IL-6 expression and decrease in EPO expression,
with both factors gradually returning to baseline at 14 days
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FIGURE 10 |The concentration of IL-6 measured experimentally. Cell
counts per 0.15 cm2 is the density of chondrocytes expressing IL-6 at a level
detectable by immunohistochemistry.
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FIGURE 11 |The concentration of EPO measured experimentally. Cell
counts per 0.15 cm2 is the density of chondrocytes expressing EPO at a
level detectable by immunohistochemistry.
(Figures 10 and 11, respectively), signaling the end of the injury
response cycle. It is noteworthy that our simulation does not pre-
dict a runaway pro-inflammatory response. This is also consistent
with experimental findings, which showed that the initial dam-
age done to the cartilage matrix by impact does not progress
over time. Importantly, these results imply that additional factors
beyond the single impact insult are required to drive further carti-
lage degeneration. Such factors may include synovitis or abnormal
joint loading, which accompany most joint injuries.
We bring attention to some specific features of the validation
result. Figure 11 shows higher concentrations of EPO in day 14
than earlier. In Figure 10, the concentration of IL-6 in day 7 is
higher than the concentration in day 1 or day 14. These correspond
to our simulation results in Figure 7.
We clarify that our current experimental techniques cannot
extract precise concentration values for cytokines throughout the
cartilage matrix. Instead, they measure the numbers of chondro-
cytes expressing each cytokine at a level detectable by immuno-
histochemistry (“positive cells”). Figure 12 shows these pro-
teins being expressed and then released into extracellular space.
Although there are limitations to counting only positive cells in
this fashion, for validation purposes of this model this type of
analysis is more than sufficient.
The immunohistochemistry analysis indicates relative rises and
declines in the amounts of cytokine present in and around indi-
vidual cells where they may act in autocrine or paracrine fashion.
Thus, the immunohistochemical approach gives a rough estima-
tion of the distribution of bioavailable cytokines. In this sense, we
see agreement with our predictions: the broad, nearly uniform,
distributions of IL-6, peaking near day 7; and the more unimodal
distributions of EPO, increasing steadily.
4. DISCUSSION
We present an age- and space-structured model to simulate the
development of an articular cartilage lesion after a single blunt
impact. We simplified the model to a radially symmetric geome-
try. Based on previous experimental findings, we hypothesized that
the consequences of mechanical trauma to cartilage depend on
the balance between competing chondrolytic and chondroprotec-
tive responses of local chondrocytes. Whether damaged cartilage
is stabilized, or begins down the path to progressive degenera-
tion, has been regarded as a matter of great biologic complexity.
However, our mathematical simulation confirms that the com-
plex behavior of this system can be modeled using just two
cytokines with opposing pro- and anti-inflammatory activities.
The post-injury pattern of expression for IL-6 and EPO indicated
by immunohistology suggests they may play roles in this binary
system.
Our model did not predict runaway degeneration after a sim-
ulated impact injury. This result is appropriate and matches
bench experiments showing that explanted cartilage recovers
from impacts of similar magnitude, which cause minimal struc-
tural damage. Structurally damaging impacts deserve attention,
but will require consideration of spatial heterogeneity in the
impact site, which is beyond the scope of the current work.
In addition, extrinsic factors that are sure to influence carti-
lage recovery in vivo, including mechanical stress and synovitis,
must eventually be incorporated in the simulation to predict
in vivo outcomes. Adding synovitis to our model as a second
source of pro-inflammatory/pro-chondrolytic cytokines is com-
putationally straightforward, but awaits parameterization data
from in vivo models. Adding mechanical stress effects involves
a much more extensive effort to combine our biomathematical
model with a finite element model, which is the subject of ongoing
research.
In summary, although our simulation results were obtained
using a relatively small number of approximated parameters, our
calculations provide useful predictions of the formation of car-
tilage lesions after a single blunt impact. Although we limited
simulations to only 2 weeks in this work, it is possible to predict
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FIGURE 12 |The concentration of EPO as a function of “positive cells.”
Each scale bar is 100µ. Immunohistochemistry images were analyzed for
“positive cells,” indicating that they were above the background thresholding
technique and within our cell size criteria. (A) shows concentration at day 1 at
the impact site, (B) at day 7 at the impact site, (C) at day 14 at the impact site,
(D) at day 1 a distance 2 mm from the impact site, (E) at day 7 at 2 mm away,
and (F) at day 14 at 2 mm away. We see clearly EPO being less constitutively
expressed at day 1, when compared to day 7 or 14.
outcomes over the much longer time frames. Thus, our in sil-
ico approach may ultimately enable us to examine the long-term
effects of various joint injury scenarios in people, which is difficult
or impossible to address in experimental models.
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